Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A NORwegian Multicentre Randomised Controlled Trial Assessing the Effectiveness of Tailoring Infliximab Treatment by Therapeutic DRUg Monitoring - The NOR-DRUM Study

NCT03074656 is registered in ClinicalTrials.gov with Diakonhjemmet Hospital as lead sponsor.

NCT NCT03074656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A NORwegian Multicentre Randomised Controlled Trial Assessing the Effectiveness of Tailoring Infliximab Treatment by Therapeutic DRUg Monitoring - The NOR-DRUM Study
Lead sponsor
Diakonhjemmet Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
December 14, 2020
Enrollment
611 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, crohn disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, spondyloarthritis, ulcerative colitis